Affymax Technologies, N.v.
Patents = 88
Trademarks = 2
Forward Citations = 18,089
where 'Filed Patents' based on already Granted Patents
where 'Inventors Filed' based on already Granted Patents
75 inventors (with patents filed for the assignee):
Affymax Technologies is a leading biotechnology company specializing in the development of innovative therapies for kidney-related diseases. With a focus on advancing patient care and improving outcomes, Affymax is dedicated to developing breakthrough treatments that address the unmet needs of patients suffering from chronic kidney conditions. Through extensive research, innovative technologies, and strategic partnerships, Affymax is committed to transforming the treatment landscape and improving the lives of patients worldwide.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com